These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28341062)

  • 1. The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up.
    Tam MM; Wu SP; Perez C; Gerber NK
    Radiother Oncol; 2017 Apr; 123(1):10-14. PubMed ID: 28341062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
    Zeidan YH; Habib JG; Ameye L; Paesmans M; de Azambuja E; Gelber RD; Campbell I; Nordenskjöld B; Gutiérez J; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Joseph DJ; Crown J; Piccart-Gebhart M; Francis PA
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):316-324. PubMed ID: 29534902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
    Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
    Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
    Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
    Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
    Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
    McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying factors impacting the efficacy of postmastectomy radiotherapy in patients with early-stage breast cancer and one to two positive lymph nodes.
    Bhutiani N; Egger ME; Stromberg AJ; Bhutiani IK; Ajkay N; McMasters KM
    J Surg Oncol; 2020 Aug; 122(2):128-133. PubMed ID: 32334441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes.
    Geng W; Zhang B; Li D; Liang X; Cao X
    J Radiat Res; 2013 Jul; 54(4):712-8. PubMed ID: 23392824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
    Chang DT; Feigenberg SJ; Indelicato DJ; Morris CG; Lightsey J; Grobmyer SR; Copeland EM; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1043-51. PubMed ID: 17336214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
    Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
    Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.
    Kayali M; Abi Jaoude J; Tfayli A; El Saghir N; Poortmans P; Zeidan YH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102880. PubMed ID: 32045847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.